NEW YORK (GenomeWeb News) – CombiMatrix said today that it has entered into an agreement with Stratose to provide coverage for its menu of diagnostic laboratory services, including its CombiSNP chromosomal microarray test.

Atlanta-based Stratose maintains a large preferred provider organization network in the US, including more than 850,000 direct and affiliate medical, dental, and workers' compensation provider contracts. Members of these plans will now have access to CombiMatrix's suite of tests for use in prenatal, miscarriage, and pediatric healthcare.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.